Image de couverture de livre

Staging Language‐Led Neurodegenerative Diseases in a Language‐Based World: The Challenge of the PPA ‐Squared Scale

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Salvatore Mazzeo, Massimo Filippi, Maria Salsone
Format:	Artículo Open Access
Publié:	Wiley 2026
Sujets:	European Journal of Neurology
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Criminal Behavior in Early Onset Neurodegenerative Diseases
par: Helmi Soppela, et autres
Publié: (2025)

Applicability and Correlates of a Symptom‐Led Staging System for Primary Progressive Aphasia
par: Edoardo Nicolò Aiello, et autres
Publié: (2025)

Cognitive Impairment Beyond Neurodegenerative Dementias: New Frontiers for Cognition in Neurological Disease
par: Paulo Caramelli, et autres
Publié: (2026)

Quantitative Brain MRI Analysis in Neurodegenerative Langerhans Cell Histiocytosis
par: Chooyoung Baek, et autres
Publié: (2025)

High Prevalence of GALC Gene Variants in Adults With Neurodegenerative Conditions
par: Federica Feo, et autres
Publié: (2025)

Contribution of Polygenic Scores to Progression Independent of Relapse Activity in Multiple Sclerosis
par: Ferdinando Clarelli, et autres
Publié: (2025)

Dysphagia in primary progressive aphasia: Clinical predictors and neuroanatomical basis
par: Salvatore Mazzeo, et autres
Publié: (2024)

Interventions for Migraine and Sleep: A Systematic Review Exploring Their Bidirectional Association
par: Marco Sforza, et autres
Publié: (2026)

Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real‐life study
par: Laura Zanandrea, et autres
Publié: (2024)

Analysis of individual alpha frequency in a large cohort from a tertiary memory center
par: Giordano Cecchetti, et autres
Publié: (2024)

Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa–Carbidopa Intestinal Gel: A Nation‐Wide, Multicenter, Longitudinal, “Real‐World” Study. The EPIC Study
par: Roberto Cilia, et autres
Publié: (2025)

Low Sensitivity of Neuropsychological Scales Hinder Detection of Potential Benefit of Treatments in Alzheimer's Disease: A Position Paper
par: Simona Luzzi, et autres
Publié: (2026)

The Medical Burden of Drug‐Resistant Epilepsy in an Outpatient Clinic of a Tertiary Hospital: A Prospective Study Based on Real‐World Evidence
par: Maria Grávalos, et autres
Publié: (2025)

Inclusive Language for Inclusive Care—A Proposal for an LGBTQI + Glossary for European Neurologists
par: Giulia Donzuso, et autres
Publié: (2026)

Migraine Patients Treated With Erenumab and the Risk of Hypertension: A Registry‐Based Real‐World Study
par: Christian Lampl, et autres
Publié: (2026)

Distinct neural signatures of pulvinar in C9orf72 amyotrophic lateral sclerosis mutation carriers and noncarriers
par: Anna Nigri, et autres
Publié: (2024)

World Federation of Neurology
par: Wolfgang Grisold
Publié: (2024)

Olfactory Dysfunction as a Window Into the Heterogeneity of Parkinson Disease
par: Yeeun Sun, et autres
Publié: (2025)

Distinctive Progression Patterns of Brain Structural Damage Aid Classification of Frontotemporal Dementia Variants
par: Edoardo Gioele Spinelli, et autres
Publié: (2025)

Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis
par: Alessio Maranzano, et autres
Publié: (2024)

Real‐World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study
par: Eleonora De Matteis, et autres
Publié: (2025)

Machine Learning Predicts Risk of Falls in Parkison's Disease Patients in a Multicenter Observational Study
par: Maria Chiara Malaguti, et autres
Publié: (2025)

Military Service and Motor Neuron Disease—Evidence From the Swedish Motor Neuron Disease Quality Registry
par: Tian Xiao, et autres
Publié: (2025)

Diagnostic Impasse and Wandering in Patients With Rare Neuromuscular Diseases: Insights Into Patient Characteristics From the French National Network for Rare Neuromuscular Diseases (FILNEMUS) and the French National Rare Disease Database (BNDMR)
par: Rémy Dumas, et autres
Publié: (2025)

Global Temporal Trends and Projections of Stroke Among Women of Childbearing Age: An Age–Period–Cohort Analysis Based on the Global Burden of Disease Study 2021
par: Dong Tang, et autres
Publié: (2025)

Neurodevelopmental Vulnerability in Alzheimer's Disease and Frontotemporal Dementia
par: Perrine Laury Marie Siguier, et autres
Publié: (2025)

Identifying Poor Responders to STN DBS in Parkinson Disease: The Role of Rapid Disease Progression in the First Year in Optimal Responders to Levodopa
par: Francesca Morgante, et autres
Publié: (2025)

Time Trends in Incidence of Motor Neuron Diseases in France: A Comprehensive 14‐Year Nationwide Study (2010–2023)
par: Octave Guinebretiere, et autres
Publié: (2025)

MOGAD in South Wales: Diagnostic Evolution and Disease Epidemiology
par: Sophie Voase, et autres
Publié: (2026)

Olfactory Dysfunction and/or RBD for Mapping Parkinson's Disease Subtypes?
par: Vittorio Velucci, et autres
Publié: (2025)

Cross‐Country Inequalities in Disease Burden and Quality of Care of Stroke, 1990–2021: A Systematic Analysis of the Global Burden of Disease Study 2021
par: Zeyu Luo, et autres
Publié: (2025)

Disease Trajectories of a Large French Cohort of 142 Congenital Myopathy Patients in Adult Age
par: Michela Bisciglia, et autres
Publié: (2025)

Staged Bilateral Magnetic Resonance‐Guided Focused Ultrasound Thalamotomy for Essential Tremor: Prospective Single‐Centre Cohort and Systematic Review With Meta‐Analysis
par: F. Paio, et autres
Publié: (2026)

Characteristics of Patients with Myasthenia Gravis in the French Rare Disease Registry
par: Jean‐Philippe Camdessanche, et autres
Publié: (2026)

The Risk of Transmission of Genetic Prion Diseases is Greater Than 50%
par: Izaro Kortazar‐Zubizarreta, et autres
Publié: (2025)

Evaluation of Sustained Disease Control With Nipocalimab Versus Placebo in the Phase 3 Vivacity‐ MG3 Study
par: Tuan Vu, et autres
Publié: (2026)

Machine‐Learning Applications in Frontotemporal Dementia: Challenges, Prospects and Viable Clinical Applications
par: Peter Bede, et autres
Publié: (2025)

Who Can Safely Discontinue Treatment in Myasthenia Gravis? Insights From a Long‐Term Real‐World Study
par: Dingxian He, et autres
Publié: (2026)

Real‐World Clinical Experience With Sodium Phenylbutyrate and Taurursodiol at a Single Amyotrophic Lateral Sclerosis Center in the United States
par: Narghes Calcagno, et autres
Publié: (2025)

Development and Validation of a Visual Grading Score of Disease Severity From Gait Videos in Genetic Peripheral Neuropathy
par: Helena F. Pernice, et autres
Publié: (2026)